{"transactions":[{"id":4624175,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-09-18T20:44:07.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":91633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule.  Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":91633,"derivative":{"underlying":"Common Stock","underlying_shares":91633},"source":{"system":"sec-edgar","filing":"0001766522-26-000017","document":"form4a-09182026_080958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000017/form4a-09182026_080958.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4624174,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-18T20:44:07.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":91633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":91633,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":91633},"source":{"system":"sec-edgar","filing":"0001766522-26-000017","document":"form4a-09182026_080958.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000017/form4a-09182026_080958.xml","form_type":"4/A","original_submission_date":"2026-09-15"}},{"id":4618671,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-09-15T23:05:06.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":91633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest on each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":91633,"derivative":{"underlying":"Common Stock","underlying_shares":91633},"source":{"system":"sec-edgar","filing":"0001766522-26-000015","document":"form4-09152026_110959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1766522/000176652226000015/form4-09152026_110959.xml","form_type":"4"}},{"id":4618670,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-15T23:05:06.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":91633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean September 15, 2026."}],"balance_after":91633,"derivative":{"exercise_price":4.09,"expiration_date":"2036-09-15","underlying":"Common Stock","underlying_shares":91633},"source":{"system":"sec-edgar","filing":"0001766522-26-000015","document":"form4-09152026_110959.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1766522/000176652226000015/form4-09152026_110959.xml","form_type":"4"}},{"id":774807,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-05-18T20:05:36.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":51020,"price":3.92,"value":199998.4,"ownership":{"direct":true},"balance_after":448126,"source":{"system":"sec-edgar","filing":"0001766522-26-000013","document":"form4-05182026_080529.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000013/form4-05182026_080529.xml","form_type":"4"}},{"id":808124,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-15T23:59:03.000Z","date":"2026-04-14","kind":"sale","planned":false,"acquired":false,"shares":92460,"price":3.64,"value":336554.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":397106,"source":{"system":"sec-edgar","filing":"0001766522-26-000011","document":"form4-04152026_110455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000011/form4-04152026_110455.xml","form_type":"4"}},{"id":808123,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-15T23:59:03.000Z","date":"2026-04-13","kind":"sale","planned":false,"acquired":false,"shares":26389,"price":3.46,"value":91305.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":489566,"source":{"system":"sec-edgar","filing":"0001766522-26-000011","document":"form4-04152026_110455.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000011/form4-04152026_110455.xml","form_type":"4"}},{"id":809606,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-14T00:34:27.000Z","date":"2026-04-10","kind":"sale","planned":false,"acquired":false,"shares":6596,"price":3.43,"value":22624.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":515955,"source":{"system":"sec-edgar","filing":"0001766522-26-000009","document":"form4-04142026_120420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000009/form4-04142026_120420.xml","form_type":"4"}},{"id":809605,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-14T00:34:27.000Z","date":"2026-04-09","kind":"sale","planned":false,"acquired":false,"shares":50000,"price":3.57,"value":178500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":522551,"source":{"system":"sec-edgar","filing":"0001766522-26-000009","document":"form4-04142026_120420.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000009/form4-04142026_120420.xml","form_type":"4"}},{"id":816113,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-04-03T22:20:30.000Z","date":"2026-04-01","kind":"grant","planned":false,"acquired":true,"shares":250058,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2026."}],"balance_after":250058,"derivative":{"exercise_price":3.54,"expiration_date":"2036-04-01","underlying":"Common Stock","underlying_shares":250058},"source":{"system":"sec-edgar","filing":"0001766522-26-000005","document":"form4-04032026_100426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000005/form4-04032026_100426.xml","form_type":"4"}},{"id":816112,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-04-03T22:20:30.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":366532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":366532},"source":{"system":"sec-edgar","filing":"0001766522-26-000005","document":"form4-04032026_100426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000005/form4-04032026_100426.xml","form_type":"4"}},{"id":816111,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-04-03T22:20:30.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":366532,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":572551,"source":{"system":"sec-edgar","filing":"0001766522-26-000005","document":"form4-04032026_100426.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000005/form4-04032026_100426.xml","form_type":"4"}},{"id":850799,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2026-03-10T23:35:11.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001766522-26-000002","document":"form4-03102026_110307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000002/form4-03102026_110307.xml","form_type":"4"}},{"id":850798,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-03-10T23:35:11.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1834,"price":3.3096,"value":6069.8064,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":206019,"source":{"system":"sec-edgar","filing":"0001766522-26-000002","document":"form4-03102026_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000002/form4-03102026_110307.xml","form_type":"4"}},{"id":850797,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2026-03-10T23:35:11.000Z","date":"2026-03-01","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."}],"balance_after":207853,"source":{"system":"sec-edgar","filing":"0001766522-26-000002","document":"form4-03102026_110307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000176652226000002/form4-03102026_110307.xml","form_type":"4"}},{"id":1179315,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-04-03T23:24:36.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":366532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":366532,"derivative":{"underlying":"Common Stock","underlying_shares":366532},"source":{"system":"sec-edgar","filing":"0001415889-25-010080","document":"form4-04032025_110433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010080/form4-04032025_110433.xml","form_type":"4"}},{"id":1179314,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2025-04-03T23:24:36.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":366532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. \"Vesting Commencement Date\" shall mean April 1, 2025."}],"balance_after":366532,"derivative":{"exercise_price":1.7,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":366532},"source":{"system":"sec-edgar","filing":"0001415889-25-010080","document":"form4-04032025_110433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925010080/form4-04032025_110433.xml","form_type":"4"}},{"id":1227756,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T23:09:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. \"Vesting Commencement Date\" shall mean March 1, 2024."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-25-006676","document":"form4-03042025_110346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006676/form4-03042025_110346.xml","form_type":"4"}},{"id":1227755,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-03-04T23:09:52.000Z","date":"2025-03-04","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":2.4,"value":240000.0,"ownership":{"direct":true},"balance_after":202853,"source":{"system":"sec-edgar","filing":"0001415889-25-006676","document":"form4-03042025_110346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006676/form4-03042025_110346.xml","form_type":"4"}},{"id":1227754,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-03-04T23:09:52.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":2147,"price":2.35,"value":5045.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units."}],"balance_after":102853,"source":{"system":"sec-edgar","filing":"0001415889-25-006676","document":"form4-03042025_110346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006676/form4-03042025_110346.xml","form_type":"4"}},{"id":1227753,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Common Stock","published_at":"2025-03-04T23:09:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001415889-25-006676","document":"form4-03042025_110346.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000141588925006676/form4-03042025_110346.xml","form_type":"4"}},{"id":2207975,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Qual. Officer & SVP Ops."}}],"security":"Common Stock","published_at":"2022-07-13T16:01:33.000Z","date":"2022-07-11","kind":"tax_withholding","acquired":false,"shares":436,"price":14.57,"value":6352.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":25178,"source":{"system":"sec-edgar","filing":"0001104659-22-079500","document":"tm2220932d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922079500/tm2220932d1_4.xml","form_type":"4"}},{"id":2297621,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Qual. Officer & SVP Ops."}}],"security":"Common Stock","published_at":"2022-04-13T16:01:36.000Z","date":"2022-04-11","kind":"tax_withholding","acquired":false,"shares":531,"price":17.19,"value":9127.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":25614,"source":{"system":"sec-edgar","filing":"0001104659-22-045468","document":"tm2212611-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922045468/tm2212611-1_4seq1.xml","form_type":"4"}},{"id":2420987,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Qual. Officer & SVP Ops."}}],"security":"Option to Purchase Common Stock","published_at":"2022-01-31T16:13:05.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":6100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 1, 2022."}],"balance_after":6100,"derivative":{"exercise_price":14.44,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":6100},"source":{"system":"sec-edgar","filing":"0001104659-22-009549","document":"tm224882-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009549/tm224882-1_4seq1.xml","form_type":"4"}},{"id":2420986,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Qual. Officer & SVP Ops."}}],"security":"Common Stock","published_at":"2022-01-31T16:13:05.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with the shares subject to the award vesting in four equal annual installments following the Vesting Commencement Date. The Vesting Commencement Date is January 1, 2022."}],"balance_after":26145,"source":{"system":"sec-edgar","filing":"0001104659-22-009549","document":"tm224882-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922009549/tm224882-1_4seq1.xml","form_type":"4"}},{"id":2435807,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Qual. Officer & SVP Ops."}}],"security":"Common Stock","published_at":"2022-01-13T19:04:40.000Z","date":"2022-01-11","kind":"tax_withholding","acquired":false,"shares":2455,"price":16.83,"value":41317.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person."}],"balance_after":22545,"source":{"system":"sec-edgar","filing":"0001104659-22-004113","document":"tm222949-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465922004113/tm222949-1_4seq1.xml","form_type":"4"}},{"id":2910775,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Option to Purchase Common Stock","published_at":"2021-01-11T19:01:24.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":39185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting and becoming exercisable in an initial annual installment following the Vesting Commencement Date and 1/48th of the shares subject to the award vesting and becoming exercisable each month thereafter. The Vesting Commencement Date is January 11, 2021."}],"balance_after":39185,"derivative":{"exercise_price":31.26,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":39185},"source":{"system":"sec-edgar","filing":"0001104659-21-003101","document":"tm212854-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921003101/tm212854-2_4seq1.xml","form_type":"4"}},{"id":2910774,"issuer":{"id":108343,"kind":"organization","name":"INTERCEPT PHARMACEUTICALS, INC.","symbol":"ICPT"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Common Stock","published_at":"2021-01-11T19:01:24.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The award shall be subject to a four-year vesting period, with 25% of the shares subject to the award vesting in an initial annual installment following the Vesting Commencement Date and the remaining shares vesting pro rata on each subsequent three-month anniversary of the Vesting Commencement Date. The Vesting Commencement Date is January 11, 2021."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001104659-21-003101","document":"tm212854-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1270073/000110465921003101/tm212854-2_4seq1.xml","form_type":"4"}},{"id":3001144,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-23T17:33:04.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":261937,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the consummation of the Merger, at the Effective Time, each option to purchase shares of Common Stock (\"Stock Option\") that was outstanding as of immediately prior to the Effective Time, whether vested or not vested, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the excess, if any, of the Offer Price over the exercise price payable per share subject to such Stock Option, multiplied by (ii) the total number of shares of Common Stock subject to such Stock Option immediately prior to the Effective Time. Any Stock Option that had an exercise price per share that was equal to or greater than the Offer Price was cancelled for no consideration."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":261937},"source":{"system":"sec-edgar","filing":"0001104659-20-117796","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117796/a4.xml","form_type":"4"}},{"id":3001143,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Common Stock","published_at":"2020-10-23T17:33:04.000Z","date":"2020-10-23","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Merger, at the Effective Time, each share of common stock, par value $0.01 per share, of the Company (\"Common Stock\") that was outstanding immediately prior to the Effective Time (other than certain shares specified in the Agreement) was automatically cancelled and converted into the right to receive $88.00 in cash (the \"Offer Price\"), without interest and subject to required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-117796","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920117796/a4.xml","form_type":"4"}},{"id":3225808,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-05T17:01:48.000Z","date":"2020-03-04","kind":"grant","acquired":true,"shares":51600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan (the \"Plan\"). The stock options vest 25% on the first anniversary of the date of grant, and on a quarterly basis thereafter over a three year period."}],"balance_after":51600,"derivative":{"exercise_price":17.16,"expiration_date":"2027-03-04","underlying":"Common Stock, par value $0.01 per share","underlying_shares":51600},"source":{"system":"sec-edgar","filing":"0001104659-20-029759","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465920029759/a4.xml","form_type":"4"}},{"id":3399852,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Common Stock, $0.01 par value per share","published_at":"2019-10-03T17:30:48.000Z","date":"2019-10-03","kind":"purchase","acquired":true,"shares":5000,"price":14.1793,"value":70896.5,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001104659-19-053001","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919053001/a4.xml","form_type":"4"}},{"id":3419184,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-10T18:00:29.000Z","date":"2019-09-10","kind":"grant","acquired":true,"shares":10440,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments over a three-year period thereafter."}],"balance_after":10440,"derivative":{"exercise_price":15.59,"exercise_date":"2020-09-10","expiration_date":"2026-09-10","underlying":"Common Stock, par value $0.01 per share","underlying_shares":10440},"source":{"system":"sec-edgar","filing":"0001104659-19-049586","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919049586/a4.xml","form_type":"4"}},{"id":3419183,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-09-10T18:00:29.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":57040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Issuer's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant, and in 6.25% in equal quarterly installments over a three-year period thereafter."}],"balance_after":57040,"derivative":{"exercise_price":13.19,"exercise_date":"2020-09-06","expiration_date":"2026-09-06","underlying":"Common Stock, par value $0.01 per share","underlying_shares":57040},"source":{"system":"sec-edgar","filing":"0001104659-19-049586","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919049586/a4.xml","form_type":"4"}},{"id":3482018,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Common Stock, $0.01 par value per share","published_at":"2019-06-21T08:47:07.000Z","date":"2019-06-20","kind":"purchase","acquired":true,"shares":5000,"price":13.35,"value":66750.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001104659-19-036862","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919036862/a4.xml","form_type":"4"}},{"id":3607350,"issuer":{"id":145732,"kind":"organization","name":"IMMUNOMEDICS INC","symbol":"IMMU"},"owners":[{"id":46413,"kind":"person","name":"BALL BRYAN","position":1,"cik":"0001766522","reported_name":"BALL BRYAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Quality Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-03-07T18:39:16.000Z","date":"2019-03-05","kind":"grant","acquired":true,"shares":142857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 6.025% on a quarterly basis thereafter."}],"balance_after":142857,"derivative":{"exercise_price":16.96,"exercise_date":"2020-03-05","expiration_date":"2026-03-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":142857},"source":{"system":"sec-edgar","filing":"0001104659-19-013436","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/722830/000110465919013436/a4.xml","form_type":"4"}}]}